Cboe CA - Delayed Quote CAD
Verano Holdings Corp. (VRNO.NE)
At close: 3:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
920,973.0000
938,452.0000
879,412.0000
737,850.0000
228,530.0000
--
Cost of Revenue
442,843.0000
463,246.0000
456,350.0000
406,831.0000
92,961.0000
--
Gross Profit
478,130.0000
475,206.0000
423,062.0000
331,019.0000
135,569.0000
--
Operating Expense
349,383.0000
331,928.0000
356,569.0000
270,929.0000
43,263.0000
--
Operating Income
128,747.0000
143,278.0000
66,493.0000
60,090.0000
92,306.0000
--
Net Non Operating Interest Income Expense
-59,226.0000
-59,793.0000
-49,431.0000
-24,270.0000
-10,458.0000
--
Other Income Expense
-60,003.0000
-55,687.0000
-180,465.0000
13,170.0000
604.0000
--
Pretax Income
9,518.0000
27,798.0000
-163,403.0000
48,990.0000
82,452.0000
--
Tax Provision
131,154.0000
145,146.0000
105,470.0000
103,988.0000
42,296.0000
--
Net Income Common Stockholders
-121,636.0000
-117,348.0000
-269,164.0000
-57,507.0000
38,401.0000
--
Diluted NI Available to Com Stockholders
-121,636.0000
-117,348.0000
-269,164.0000
-57,507.0000
38,401.0000
--
Basic EPS
-0.35
-0.33
-0.81
-0.20
0.13
--
Diluted EPS
-0.35
-0.33
-0.81
-0.20
0.13
--
Basic Average Shares
346,417.1440
344,074.0960
331,409.3150
290,443.4320
289,999.9980
--
Diluted Average Shares
346,417.1440
344,074.0960
331,409.3150
290,443.4320
289,999.9980
--
Total Operating Income as Reported
70,514.0000
84,784.0000
-161,131.0000
64,713.0000
94,998.0000
--
Total Expenses
792,226.0000
795,174.0000
812,919.0000
677,760.0000
136,224.0000
--
Net Income from Continuing & Discontinued Operation
-121,636.0000
-117,348.0000
-269,164.0000
-57,507.0000
38,401.0000
--
Normalized Income
-68,766.0000
-81,363.6000
-111,502.0723
-56,709.5250
39,420.4450
--
Interest Expense
59,226.0000
59,793.0000
49,431.0000
24,270.0000
7,440.0000
--
Net Interest Income
-59,226.0000
-59,793.0000
-49,431.0000
-24,270.0000
-10,458.0000
--
EBIT
68,744.0000
87,591.0000
-113,972.0000
73,260.0000
89,892.0000
--
EBITDA
222,989.0000
239,217.0000
36,353.0000
169,504.0000
97,758.0000
--
Reconciled Cost of Revenue
442,843.0000
463,246.0000
456,350.0000
406,831.0000
85,095.0000
--
Reconciled Depreciation
154,245.0000
151,626.0000
150,325.0000
96,244.0000
7,866.0000
--
Net Income from Continuing Operation Net Minority Interest
-121,636.0000
-117,348.0000
-269,164.0000
-57,507.0000
38,401.0000
--
Total Unusual Items Excluding Goodwill
-62,200.0000
-59,974.0000
-213,663.0000
-1,085.0000
-1,387.0000
--
Total Unusual Items
-62,200.0000
-59,974.0000
-213,663.0000
-1,085.0000
-1,387.0000
--
Normalized EBITDA
285,189.0000
299,191.0000
250,016.0000
170,589.0000
99,145.0000
--
Tax Rate for Calcs
0.0002
0.0004
0.0003
0.0003
0.0003
--
Tax Effect of Unusual Items
-9,330.0000
-23,989.6000
-56,001.0723
-287.5250
-367.5550
--
12/31/2019 - 2/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AYR-A.CN Ayr Wellness Inc.
3.1900
+18.59%
CBST.NE The Cannabist Company Holdings Inc.
0.3450
+16.95%
CL.CN Cresco Labs Inc.
2.3300
+7.87%
TSND.TO TerrAscend Corp.
1.7200
+3.61%
GTII.CN Green Thumb Industries Inc.
15.23
+7.25%
CURA.TO Curaleaf Holdings, Inc.
4.8900
+12.93%
TRUL.CN Trulieve Cannabis Corp.
18.45
+7.96%
CXXI.CN C21 Investments Inc.
0.3400
+13.33%
TIUM-U.CN Cansortium Inc.
0.1600
+10.34%
CXXIF C21 Investments Inc.
0.2400
+4.35%